ArticlePloS one2025
Stakeholder communication and client understanding of viral load suppression in Blantyre, Malawi-What role did U = U play before the flip the script campaign?
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- U = U for all: Advancing equity in HIV prevention.PLoS medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVarious studies have demonstrated the effectiveness of viral load suppression (VLS) in preventing sexual transmission of the human immunodeficiency virus (HIV), leading to the slogan "Undetectable = Untransmittable" or "U = U". As few studies have examined health stakeholders' understandings of U = U, the communication of a suppressed viral load (VL) to male clients, and male clients' understandings of the benefits of a suppressed VL in Sub-Saharan Africa, we explore these in this study. In the field of HIV, it is only in recent years that men who have sex with women (MSW) have been given some attention. The treatment cascade shows that MSW lag behind women in knowing their HIV-status, accessing treatment and suppressing their VL. METHODS AND
findingsOur findings are based on in-depth qualitative semi-structured in-person interviews with 16 local stakeholders (health facility personnel, NGO and church-based HIV programme implementers and applied researchers) and 39 men on antiretroviral treatment (ART) in Blantyre, Malawi: Twenty-three men with a detectable VL and 16 with a suppressed VL were included in the study. Thematic analysis of the audio-recorded and transcribed interviews show that stakeholders were mostly unfamiliar with the slogan U = U. Despite realizing the advantages for clients and their partners, stakeholders were cautious about how they conveyed information about an undetectable VL: they were worried about clients either misinterpreting an undetectable VL as being cured of HIV or engaging in risky sexual behaviour. This attitude prevailed irrespective of the degree of stakeholders' endorsement of the evidence of U = U. Male clients were aware of personal health benefits of a suppressed VL, yet unaware of their non-infectiousness. In order not to infect others, some men ceased sexual relations or forwent procreation.
conclusionFor U = U to become part of a client's actionable knowledge with regard to treatment benefits, U = U needs to be communicated comprehensively. To what extent recent policy changes, the Flip the Script campaign to make U = U known and staff training programs have led to a different practice will need to be further researched, using our findings as a reference point. Integrated health services are already in place; however, VL monitoring, and testing and treatment for sexually transmitted infections (STIs) should ideally be conducted more frequently than annually, so that Malawian clients can be assured of their VL status and of not passing on the virus while also being able to get any STIs treated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.